ARCHIVES

Celgene Begins Two Studies With Hoffmann-La Roche.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001

UICC Names Banker As Chief Executive

September 11, 2009

NCI Virus Program Has “Important Extension of Virology” as New Approach To Etiology

April 23, 1976

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997